Risk factors associated with the postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas

Pancreas

Volumn 40, Issue 1, 2011, Pages 46-51

  Park, Jongwook ^a   Lee, Kyu Taek ^a   Jang, Tae Hoon ^a   Seo, Yong Woo ^a   Lee, Kwang Hyuck ^a   Lee, Jong Kyun ^a   Jang, Kee Taek ^a   Heo, Jin Seok ^a   Choi, Seong Ho ^a   Choi, Dong Wook ^a   Rhee, Jong Chul ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

IPMN; pancreas; postoperative; recurrence; risk factor

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR RECURRENCE;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CA-19-9 ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 78650953438     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181f66b74     Document Type: Article

References (37)

1. Morohoshi T, Kanda M, Asanuma K, et al. Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer. 1989;64:1329-1335.
2. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6: 17-32.
3. Agostini S, Choux R, Payan MJ, et al. Mucinous pancreatic duct ectasia in the body of the pancreas. Radiology. 1989;170:815-816.
4. Farrell JJ, Brugge WR. Intraductal papillary mucinous tumor of the pancreas. Gastrointest Endosc. 2002;55:701-714.
5. Kosmahl M, Pauser U, Peters K, et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 2004;445: 168-178.
6. Maire F, Hammel P, Terris B, et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut. 2002; 51:717-722.
7. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678-685; discussion 685-677.
8. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg. 1998;228:685-691.
9. Raimondo M, Tachibana I, Urrutia R, et al. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol. 2002;97:2553-2558.
10. Kanazumi N, Nakao A, Kaneko T, et al. Surgical treatment of intraductal papillary-mucinous tumors of the pancreas. Hepatogastroenterology. 2001;48:967-971.
11. Kloeppel G, Solcia E, Longnecker DS, et al. Histological typing of tumours of the exocrine pancreas. In: World Health Organization International Histological Classification of Tumours. 2nd ed. Berlin, Germany: Springer; 1996.
12. Solcia E, Capella C, Kloeppel G. Tumors of the pancreas. In: Atlas of Tumor Pathology, 3rd series. Washington, DC: Armed Forces of Pathology; 1997.
13. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788-797.
14. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004; 28:977-987.
15. Biankin AV, Kench JG, Dijkman FP, et al. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology. 2003;35:14-24.
16. Salvia R, Bassi C, Falconi M, et al. Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop? JOP. 2005;6:112-117.
17. Sakorafas GH, Sarr MG, van de Velde CJ, et al. Intraductal papillary mucinous neoplasms of the pancreas: a surgical perspective. Surg Oncol. 2005;14:155-178.
18. Gourgiotis S, Ridolfini MP, Germanos S. Intraductal papillary mucinous neoplasms of the pancreas. Eur J Surg Oncol. 2007;33:678-684.
19. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500-1507.
20. Schnelldorfer T, Sarr MG, Nagorney DM, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639-646; discussion 646.
21. Bassi C, Sarr MG, Lillemoe KD, et al. Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg. 2008;12:645-650.
22. Furukawa T, Takahashi T, Kobari M, et al. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer. 1992;70: 1505-1513.
23. Lim JH, Lee G, Oh YL. Radiologic spectrum of intraductal papillary mucinous tumor of the pancreas. Radiographics. 2001;21:323-337; discussion 337-340.
24. Murakami Y, Uemura K, Hayashidani Y, et al. Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg. 2007;11:338-344.
25. Raut CP, Cleary KR, Staerkel GA, et al. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol. 2006;13:582-594.
26. Siech M, Tripp K, Schmidt-Rohlfing B, et al. Intraductal papillary mucinous tumor of the pancreas. Am J Surg. 1999;177:117-120.
27. Kim SC, Park KT, Lee YJ, et al. Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center. J Hepatobiliary Pancreat Surg. 2008;15:183-188.
28. Rivera JA, Fernandez-del Castillo C, Pins M, et al. Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Ann Surg. 1997;225:637-644; discussion 644-636.
29. Kitagawa Y, Unger TA, Taylor S, et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg. 2003;7:12-18; discussion 18-19.
30. Nara S, Onaya H, Hiraoka N, et al. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009;38:8-16.
31. Imaizumi T, Hatori T, Harada N, et al. Intraductal papillary mucinous neoplasm of the pancreas; resection and cancer prevention. Am J Surg. 2007;194:S95YS99.
32. Paye F, Sauvanet A, Terris B, et al. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Surgery. 2000;127:536-544.
33. Traverso LW, Peralta EA, Ryan JA Jr, et al. Intraductal neoplasms of the pancreas. Am J Surg. 1998;175:426-432.
34. Zamora C, Sahel J, Cantu DG, et al. Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature. Am J Gastroenterol. 2001;96: 1441-1447.
35. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799.
36. Nakamura A, Horinouchi M, Goto M, et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. J Pathol. 2002;197:201-210.
37. Yonezawa S, Higashi M, Yamada N, et al. Precursor lesions of pancreatic cancer. Gut Liver. 2008;2:137-154.